Thermo Fisher Scientific Inc., the second-biggest maker of life-sciences equipment by market value, agreed to buy Life Technologies Corp. for $13.6 billion in cash in a deal that expands its reach in medical testing.
Thermo Fisher Scientific Inc. is the leading bidder for Life Technologies Corp., having won exclusive negotiating rights over the weekend with a bid for more than $75 a share, said two people familiar with the matter.
Life Technologies Corp. got takeover offers from a private-equity group including Blackstone Group LP, and from Thermo Fisher Scientific Inc., for as much as $11.8 billion, said people familiar with the matter.
Patients who undergo broad DNA testing to explain a specific medical condition also should be told about chance findings that indicate risk for other serious diseases, a group of genetic specialists said.
A buyout group comprising Blackstone Group LP, Carlyle Group, TPG Capital and Temasek Holdings Pte is exploring an offer for Life Technologies Corp., a maker of DNA- sequencing equipment and laboratory materials, said people with knowledge of the matter.